Optimize potential performance of your biotherapeutics by calibrating dosage and investigating the efficacy of therapeutic effect based on highly specific and quantitative genotyping and gene expression. Increase your confidence in product safety by identifying and quantifying on-target and off-target toxicity and contaminating pathogens using highly specific and sensitive gene expression, sequencing, and dPCR. Maximize trial efficiency by including genetic analysis to refine cohort selection, which can also enable investigation into disease response risk and pharmacogenomics.
Drive studies to reveal impacts of dosing, biotherapeutics, or multi-drug therapies on gene expression by assessing genetic impact on target and off-target tissues and on expression of genes.
Explore variability in responses to treatments, differentiate genetic vs. lifestyle contributors to disease, and investigate biomarkers for personalized therapies with genotypic stratification.
Inspire new approaches to assessment of variability among drug metabolism genes and the relationships between genetic variations and drug response with pharmacogenomic profiling.
Download to learn:
Discover QualTrak qPCR and dPCR workflows for mAbs, vaccines, and cell and gene therapies across biopharmaceutical development and manufacturing.
Efficiently develop and characterize recombinant monoclonal antibodies (mAbs) from discovery through clinical trials and manufacturing by incorporating genetic-level analysis into your workflows.
We support you with exceptional services, remote tools, training, and OEM expertise we’ve spent 40 years curating.
Download flyer ›